157 related articles for article (PubMed ID: 25960883)
1. Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.
Ward DR; Moist LM; MacRae JM; Scott-Douglas N; Zhang J; Tonelli M; Lok CE; Soroka SD; Hemmelgarn BR
Can J Kidney Health Dis; 2014; 1():15. PubMed ID: 25960883
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
[TBL] [Abstract][Full Text] [Related]
3. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
4. Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449].
Hemmelgarn BR; Moist L; Pilkey RM; Lok C; Dorval M; Tam PY; Berall MJ; LeBlanc M; Toffelmire EB; Manns BJ; Scott-Douglas N;
BMC Nephrol; 2006 Apr; 7():8. PubMed ID: 16608513
[TBL] [Abstract][Full Text] [Related]
5. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator vs heparin for locking central venous catheters between apheresis procedures.
Mathur G; Mott SL; Collins L; Schlueter AJ
J Clin Apher; 2019 Aug; 34(4):445-449. PubMed ID: 30829414
[TBL] [Abstract][Full Text] [Related]
7. Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial.
Richtrova P; Mares J; Kielberger L; Klaboch J; Eiselt J; Reischig T
BMC Nephrol; 2021 Jan; 22(1):41. PubMed ID: 33509107
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the safety and efficacy of argatroban locking solution in the prevention of the dysfunction of haemodialysis central venous catheters: a study protocol for a randomized controlled trial.
Wang Y; Liu C; Zhang L; Li J; Zhang L; Wang Y; Zhu H; Cao X; Wu D; Wu J; Lin S; Feng Z; Cai G; Chen X; Sun X
Ann Palliat Med; 2021 Feb; 10(2):2260-2270. PubMed ID: 33549029
[TBL] [Abstract][Full Text] [Related]
9. Femoral localization and higher ultrafiltration rate but not concentration of heparin used for canal locking of hemodialysis catheter are negative predictors for its malfunction.
Brzosko S; Hryszko T; Malyszko J; Malyszko JS; Mazerska M; Myśliwiec M
Am J Nephrol; 2008; 28(2):298-303. PubMed ID: 18025778
[TBL] [Abstract][Full Text] [Related]
10. An economic evaluation of rt-PA locking solution in dialysis catheters.
Manns BJ; Scott-Douglas N; Tonelli M; Ravani P; LeBlanc M; Dorval M; Holden R; Moist L; Lok C; Zimmerman D; Au F; Hemmelgarn BR
J Am Soc Nephrol; 2014 Dec; 25(12):2887-95. PubMed ID: 25012176
[TBL] [Abstract][Full Text] [Related]
11. Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.
Poinen K; Quinn RR; Clarke A; Ravani P; Hiremath S; Miller LM; Blake PG; Oliver MJ
Am J Kidney Dis; 2019 Apr; 73(4):467-475. PubMed ID: 30642607
[TBL] [Abstract][Full Text] [Related]
12. Low dose heparin lock (1000 U/mL) maintains tunnelled hemodialysis catheter patency when compared with high dose heparin (5000 U/mL): A randomised controlled trial.
Chu G; Fogarty GM; Avis LF; Bergin S; McElduff P; Gillies AH; Choi P
Hemodial Int; 2016 Jul; 20(3):385-91. PubMed ID: 26833752
[TBL] [Abstract][Full Text] [Related]
13. Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap.
Hymes JL; Mooney A; Van Zandt C; Lynch L; Ziebol R; Killion D
Am J Kidney Dis; 2017 Feb; 69(2):220-227. PubMed ID: 27839894
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intensive versus standard hemodialysis central venous catheter dysfunction protocol using rt-PA: a quality assurance initiative.
Wilson JA; Mossop P; Soroka SD; Dipchand C; Drost S; Sheehy N; Tennankore K
J Vasc Access; 2016; 17(2):143-50. PubMed ID: 26847735
[TBL] [Abstract][Full Text] [Related]
15. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
[TBL] [Abstract][Full Text] [Related]
16. Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters.
Lok CE; Appleton D; Bhola C; Khoo B; Richardson RM
Nephrol Dial Transplant; 2007 Feb; 22(2):477-83. PubMed ID: 17018541
[TBL] [Abstract][Full Text] [Related]
17. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.
Bonkain F; Van Hulle F; Janssens P; Catalano C; Allamani M; Stolear JC; Vandervelde D; Libertalis M; Treille S; Couttenye MM; Dhondt A; Van Biesen W; Fils JF; Tielemans C; Wissing KM
J Vasc Access; 2017 Sep; 18(5):436-442. PubMed ID: 28623638
[TBL] [Abstract][Full Text] [Related]
19. Predicting tissue plasminogen activator use and success in in-center hemodialysis patients.
Kosa SD; Ye C; Thabane L; Gafni A; Lok CE
J Vasc Access; 2018 Mar; 19(2):146-152. PubMed ID: 28983900
[TBL] [Abstract][Full Text] [Related]
20. Fourteen years of hemodialysis with a central venous catheter: mechanical long-term complications.
Di Iorio BR; Mondillo F; Bortone S; Nargi P; Capozzi M; Spagnuolo T; Cucciniello E; Bellizzi V
J Vasc Access; 2006; 7(2):60-5. PubMed ID: 16868898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
